Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jul;6(7):562-563.
doi: 10.1016/S2215-0366(19)30219-6.

Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' reply

Mark Abie Horowitz  1 , David Taylor  2
Affiliations
Comment

Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' reply

Mark Abie Horowitz et al. Lancet Psychiatry. 2019 Jul.
No abstract available

PubMed Disclaimer

Comment on

  • Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Kronenberg G, Desai D, Anghelescu I. Kronenberg G, et al. Lancet Psychiatry. 2019 Jul;6(7):560. doi: 10.1016/S2215-0366(19)30184-1. Lancet Psychiatry. 2019. PMID: 31230675 No abstract available.
  • Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Selvaraj S, Jauhar S, Baldwin DS, Cowen PJ, Goodwin G, Hayes JF, Nutt DJ, Veronese M, Young AH. Selvaraj S, et al. Lancet Psychiatry. 2019 Jul;6(7):560-561. doi: 10.1016/S2215-0366(19)30183-X. Lancet Psychiatry. 2019. PMID: 31230676 Free PMC article. No abstract available.
  • Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Ruhe HG, Horikx A, van Avendonk MJP, Groeneweg BF, Woutersen-Koch H; Discontinuation of Antidepressants Taskforce. Ruhe HG, et al. Lancet Psychiatry. 2019 Jul;6(7):561-562. doi: 10.1016/S2215-0366(19)30182-8. Lancet Psychiatry. 2019. PMID: 31230677 No abstract available.

LinkOut - more resources